December 2014 - Cancer Currents Blog
-
Which Patients Will Benefit from Immunotherapy for Cancer? Some Hints EmergeResearchers have identified a “genetic signature” in the tumors of patients with advanced melanoma who responded to a form of immunotherapy called checkpoint blockade. The results could be the basis for a test that identifies likely responders to this treatment as well as for developing new treatments.
-
Method for Identifying Combination Therapies to Combat Treatment Resistance Shows PromiseResearchers from the Massachusetts General Hospital Cancer Center in Boston have reported on a method for studying treatment resistance that may identify combinations of targeted therapies that can help to combat resistance in some patients.
-
Debate, Research on E-Cigarettes ContinueSince they first began to be sold in North America in the mid-2000s, electronic cigarettes have been the subject of intense debate. NCI's Dr. Michele Bloch recently presented an update on some of the issues surrounding e-cigarettes.
-
Building on Opportunities in Cancer Research: NCI’s Annual Plan and Budget Proposal for FY 2016NCI’s Director, Dr. Harold Varmus, introduces the NCI Annual Plan and Budget Proposal for Fiscal Year 2016.